Life Science Company News

Ambu A/S: Capital increase in connection with exercise of warrants issued

In December 2013, Ambu A/S issued 400,000 warrants, each warrant entitling the holder to subscribe for one Class B share with a nominal value of DKK 2.50. These warrants were issued to 52 employees with a vesting period of three years and may therefore be exercised in the trading window which was opened 9 November 2017 in connection with Ambu's Annual Report 2016/17.


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Ambu A/S via GlobeNewswire

HUG#2151378
By: Nasdaq / GlobeNewswire - 22 Nov 2017
Back to overview

Enhance your business development with Biotechgate